Mark Dmytruk
2021
In 2021, Mark Dmytruk earned a total compensation of $40.1M as Chief Financial Officer at Ginkgo Bioworks Holdings, a 60,053% increase compared to previous year.
Compensation breakdown
| Salary | $425,000 |
|---|---|
| Stock Awards | $39,629,178 |
| Other | $14,500 |
| Total | $40,068,678 |
Dmytruk received $39.6M in stock awards, accounting for 99% of the total pay in 2021.
Dmytruk also received $425K in salary and $14.5K in other compensation.
Rankings
In 2021, Mark Dmytruk's compensation ranked 95th out of 12,415 executives tracked by ExecPay. In other words, Dmytruk earned more than 99.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 95 out of 12,415 | 99th |
Division Manufacturing | 29 out of 5,505 | 100th |
Major group Chemicals And Allied Products | 9 out of 2,375 | 100th |
Industry group Drugs | 7 out of 2,096 | 100th |
Industry Biological Products, Except Diagnostic Substances | 4 out of 449 | 99th |
Source: SEC filing on April 26, 2022.
Dmytruk's colleagues
We found two more compensation records of executives who worked with Mark Dmytruk at Ginkgo Bioworks Holdings in 2021.